Best Small Cap Stocks this January 2026

FiEE Inc (FIEE) has delivered an impressive one-year return of 612.36%, marking it as a strong contender on major U.S. exchanges. With a focus on financial health and robust performance, analysts at Northland Capital Markets maintain an "Outperform" rating, while B. Riley Securities rates it as a "Buy." Despite a challenging five-year return of -96.23%, the company's recent trajectory showcases its potential for recovery and growth.

LiveRamp (RAMP) presents an appealing investment opportunity with a projected EPS growth of 30.59%. Despite a recent price change of 2.16%, the stock has faced challenges, reflected in a 1-year return of -5.11% and a steep 5-year return of -66.93%. With analysts offering a consensus rating of "Hold" and a median price target of $53.00, investors may find value in its potential to outperform the market over the next 12 months.

Ramp stock has a strong potential to outperform the market in the next 12 months.

The average 12-month price target for Ramp stock is $39.80, with a range between $31.00 and $53.00, indicating a potential increase of 43.32% from its current price of $27.77.

LiveRamp has a consensus rating of 'Hold' from 7 Wall Street analysts, with 1 sell, 3 hold, 2 buy, and 1 strong buy ratings.

Oncology Institute Inc (TOI) has delivered an impressive one-year return of 1135.16%, making it a standout performer in the market. However, investors should be cautious as the company’s five-year return is notably negative at -64.48%, raising questions about its long-term growth prospects. Analysts maintain a median price target of $5.00, suggesting a potential upside, but with projected revenue growth stagnating, TOI's future remains uncertain.

TOI has a consensus rating of Strong Buy from three analysts, but its revenue growth is projected to stagnate, which could negatively impact its financial performance.

TOI's current price is $3.67, reflecting a 3.09% increase in the past 24 hours.

Analysts have set an average price target of $6.63 for TOI, indicating a potential price increase of 69.13% over the next year.

AXT Inc (AXTI) stands out as a small-cap stock, boasting an impressive one-year return of 1006.47%, making it the fifth-best performer in its category. Analysts currently have a mixed view, with a consensus rating of "Hold," but varying price targets ranging from $7.00 to $26.00 indicate potential volatility. For investors considering growth, AXT's recent technical signals suggest a positive trend starting in late 2025, with expectations of a 143.02% price change.

AXTI has a consensus rating of 'Hold' from 5 Wall Street analysts, with 1 sell, 1 hold, and 3 buy ratings.

AXTI's main competitors in the semiconductor equipment industry include Axcelis Technologies (ACLS), Photronics (PLAB), Veeco Instruments (VECO), Ultra Clean (UCTT), and PDF Solutions (PDFS).

Array Technologies (ARRY) is showing promising potential with a projected EPS growth of 44.62% and sales growth of 18.38%. Despite a significant 5-year return decline of 80.38%, analysts maintain a median 12-month price target of $10.00, with a range between $9.00 and $15.00, reflecting a cautiously optimistic outlook.

ARRY shows potential for long-term growth with a Growth Score of C and a strong Momentum Score of A, indicating it may outperform the market.

Analysts have set an average price target of $11.02 for ARRY, suggesting a potential upside of 17.23% from its current price of $9.40.

By 2028, Array Technologies is projected to achieve $1.5 billion in revenue and $98.4 million in earnings, indicating a fair value of $10.97, which is a 15% upside from its current price.

Currently, Array Technologies is not profitable, with expected earnings of $98.4 million by 2028, improving from current losses of $265.9 million.

Hycroft Mining Holding Corporation (HYMC) has achieved an impressive one-year return of 1525.62%, positioning it as a notable player in the market, though caution is advised for potential investors. Analysts have recently downgraded their ratings, reflecting concerns about HYMC’s financial stability and history of restructuring, which could impact its growth prospects. Despite its remarkable short-term performance, the stock trades at a high price-to-book ratio of 41.6x, suggesting that investors should weigh these valuation concerns against its recent gains.

Investing in HYMC carries significant risks due to its history of financial difficulties, including restructuring and ongoing cash burn, making it reliant on dilutive capital raises for operations.

HYMC's price-to-book ratio of 41.6x is significantly higher than the industry average of 2.3x, indicating an aggressive valuation compared to its peers.

CION Investment Corporation stands out as a top Zacks pick, currently trading at a low forward PE of 6.63. With a substantial dividend yield of 14.35%, it may appeal to value investors seeking consistent income despite its recent one-year return of -13.36%. Analysts have a positive outlook, setting a 12-month price target between $11.50 and $13.00, reflecting confidence in CION's financial stability and growth prospects.

CION Investment Corporation has a Value Score of A, indicating it is a strong choice for value investors, with solid financial health and growth prospects.

CION typically pays dividends quarterly, with four payments per year, excluding special dividends.

CION has a trailing 12-month revenue of $244.9 million, a profit margin of 10.6%, and a dividend yield of 12.5%, with analysts expecting adjusted earnings of $1.760 per share this fiscal year.

CION's main competitors include MidCap Financial Investment (MFIC), Blue Owl Capital (OBDC), Royce Small-Cap Trust (RVT), Gabelli Equity Trust (GAB), and Nuveen Municipal Value Fund (NUV).